Global Hepatitis C Diagnosis and Treatment Market Size, Share, Forecast Report, 2020-2027

Hepatitis C Diagnosis and Treatment Market is expected to exhibit significant growth over the forecast period. The market is projected to register a 3.82% CAGR over the forecast period.

Hepatitis C is a liver infection that is caused due to the hepatitis C virus. The hepatitis C virus may cause both acute as well as chronic hepatitis. It is a bloodborne virus and is commonly infected through small quantities of blood.

Factors such as the high prevalence of hepatitis C and increasing awareness regarding the disease are expected to drive the market growth. According to an article published by the World Health Organization (WHO) in July 2019, an estimated 71 million people suffer from chronic hepatitis C virus infection, globally.

However, stringent government regulations and alternate treatment options, such as herbal treatment offered at comparatively lower prices are expected to hamper the market growth.

Segmentation

The Global Hepatitis C Diagnosis and Treatment Market has been segmented into diagnosis, treatment, end-user, and region.

Based on diagnosis, the global hepatitis C diagnosis and treatment market has been divided into liver function tests, liver biopsy, blood tests, and others.

The global hepatitis C diagnosis and treatment market, by treatment, has been segmented into antiviral medications, immune-modulators, liver transplantation, and others.

The global hepatitis C diagnosis and treatment market, by end-user, has been segmented into hospitals & clinics, diagnostic centers, and others.
Key Players

Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Incorporated (US), Gilead Sciences, Inc. (US), AbbVie Inc. (US), GlaxoSmithKline PLC (UK), Novartis Pharmaceuticals Corporation (Switzerland), Bristol-Myers Squibb Company (US), Abbott (US), Beckman Coulter, Inc. (US), Siemens Medical Solutions USA, Inc. (Germany), MedMira Inc. (Canada), DiaSorin SpA (Italy), Qiagen (Germany), bioMérieux SA (France), Hologic, Inc. (US), and Bio-Rad Laboratories, Inc. (US) are some of the Key Players operating in the Global Hepatitis C Diagnosis and Treatment Market.